Biwei Yang

1.5k total citations
50 papers, 1.1k citations indexed

About

Biwei Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Biwei Yang has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Biwei Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Mechanisms and Therapy (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Biwei Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Mechanisms and Therapy (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Biwei Yang collaborates with scholars based in China, Ethiopia and Israel. Biwei Yang's co-authors include Jinglin Xia, Wenqing Tang, Si Zhang, Peixin Huang, Tingting Fang, Meiyi Li, Luonan Chen, Weixin Liu, Feifei Yuan and Zhiying Zhao and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Biwei Yang

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biwei Yang China 18 526 370 313 215 185 50 1.1k
Wenqing Tang China 21 686 1.3× 348 0.9× 290 0.9× 150 0.7× 212 1.1× 54 1.2k
Alessio Giubellino United States 21 605 1.2× 308 0.8× 329 1.1× 164 0.8× 128 0.7× 77 1.3k
Oona Delpuech United Kingdom 20 1.1k 2.0× 460 1.2× 433 1.4× 243 1.1× 141 0.8× 33 1.7k
Chia‐Lang Hsu Taiwan 25 1.1k 2.1× 480 1.3× 364 1.2× 312 1.5× 387 2.1× 118 1.8k
Hengjun Gao China 25 1.1k 2.2× 670 1.8× 309 1.0× 131 0.6× 116 0.6× 72 1.6k
Eva Dazert Switzerland 14 878 1.7× 355 1.0× 162 0.5× 107 0.5× 267 1.4× 19 1.5k
Guang‐Zhi Jin China 25 1.2k 2.2× 733 2.0× 380 1.2× 228 1.1× 160 0.9× 48 1.7k
Yuezhen Deng China 20 1.1k 2.1× 646 1.7× 421 1.3× 130 0.6× 330 1.8× 34 1.8k
Sarah Yoon South Korea 15 574 1.1× 286 0.8× 180 0.6× 79 0.4× 118 0.6× 22 918
Gretchen Argast United States 17 1.1k 2.1× 223 0.6× 357 1.1× 98 0.5× 205 1.1× 26 1.6k

Countries citing papers authored by Biwei Yang

Since Specialization
Citations

This map shows the geographic impact of Biwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biwei Yang more than expected).

Fields of papers citing papers by Biwei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biwei Yang. The network helps show where Biwei Yang may publish in the future.

Co-authorship network of co-authors of Biwei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Biwei Yang. A scholar is included among the top collaborators of Biwei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biwei Yang. Biwei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Song, Chunyan Zhu, Qing Shi, et al.. (2024). Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression. EBioMedicine. 109. 105436–105436. 5 indexed citations
2.
3.
Li, Miao, Feng Zhang, Shan Yan, et al.. (2022). A Novel Thoracoabdominal Aorta CTA-based Nomogram Model to Identify Ideal Candidates for Transradial Approach Chemoembolization in Patients with Liver Cancer. Journal of Cancer. 13(9). 2863–2871. 1 indexed citations
4.
Huang, Peixin, Zhiying Zhao, Yi Chen, Biwei Yang, & Jinglin Xia. (2022). The E3 ubiquitin ligase SOCS-7 reverses immunosuppression via Shc1 signaling in hepatocellular carcinoma. Laboratory Investigation. 102(6). 613–620. 6 indexed citations
5.
Du, Xiaojing, Biwei Yang, Quanlin An, et al.. (2021). Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. The Innovation. 2(2). 100103–100103. 101 indexed citations
6.
Feng, Qi, Wenxing Qin, Yao Zhang, et al.. (2021). Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 17 indexed citations
7.
He, Mingyan, Jing Hu, Tingting Fang, et al.. (2021). Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway. Cancer Biology and Medicine. 18(-). 0–0. 27 indexed citations
8.
Feng, Qi, Xiaojing Du, Zhiying Zhao, et al.. (2021). Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 729340–729340. 22 indexed citations
9.
Yuan, Feifei, Donghe Li, Tingting Fang, et al.. (2020). IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner. Biochemical and Biophysical Research Communications. 523(3). 809–815. 8 indexed citations
10.
Yuan, Feifei, Qi Feng, Jialei Sun, et al.. (2020). Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis. Journal of Translational Medicine. 18(1). 306–306. 114 indexed citations
11.
Fang, Tingting, Zhiying Zhao, Feifei Yuan, et al.. (2019). Actinidia Chinensis Planch Root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway. Journal of Ethnopharmacology. 251. 112529–112529. 15 indexed citations
12.
Tang, Wenqing, Biwei Yang, Feifei Yuan, et al.. (2019). TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway. Oncogenesis. 8(2). 9–9. 54 indexed citations
13.
Weng, Shu‐Qiang, Harry L.A. Janssen, Ning‐Ping Zhang, et al.. (2019). CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma. Digestive Diseases and Sciences. 65(4). 1053–1063. 2 indexed citations
14.
Fang, Tingting, Yuan Fang, Xiaojing Xu, et al.. (2018). Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition. Journal of Ethnopharmacology. 231. 474–485. 29 indexed citations
15.
He, Mingyan, Wenhui Zhang, Yinying Dong, et al.. (2017). Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells. Journal of Experimental & Clinical Cancer Research. 36(1). 15–15. 59 indexed citations
16.
Tang, Wenqing, Xuemei Feng, Si Zhang, et al.. (2015). Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway. Cellular Physiology and Biochemistry. 36(3). 1223–1236. 44 indexed citations
17.
Xu, Xiaojing, Peixin Huang, Biwei Yang, Xiangdong Wang, & Jinglin Xia. (2014). Roles of CXCL5 on migration and invasion of liver cancer cells. Journal of Translational Medicine. 12(1). 193–193. 23 indexed citations
18.
Yang, Biwei, Dajiang Li, Li Liu, et al.. (2013). Colonic involvement in disseminated histoplasmosis of an immunocompetent adult: case report and literature review. BMC Infectious Diseases. 13(1). 143–143. 14 indexed citations
19.
Liang, Ying, Weiwei Li, Biwei Yang, et al.. (2011). Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma. International Journal of Cancer. 130(8). 1745–1754. 36 indexed citations
20.
Yang, Biwei, Jinglin Xia, Zhenggang Ren, et al.. (2010). Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation. European Journal of Radiology. 79(2). 196–200. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenqing Tang Breakdown of academic impact, for papers by Alessio Giubellino Breakdown of academic impact, for papers by Oona Delpuech Breakdown of academic impact, for papers by Chia‐Lang Hsu Breakdown of academic impact, for papers by Hengjun Gao Breakdown of academic impact, for papers by Eva Dazert Breakdown of academic impact, for papers by Guang‐Zhi Jin Breakdown of academic impact, for papers by Yuezhen Deng Breakdown of academic impact, for papers by Sarah Yoon Breakdown of academic impact, for papers by Gretchen Argast
Rankless by CCL
2026